Skip to content
Homepage
Author:
Zepto Life Technology
Posted Date:
June 3, 2026
Zepto Life Technology Receives FDA Breakthrough Device Designation for Targeted Liquid Biopsy Test for Invasive Mold Infections
Zepto Life Technology
June 3, 2026
Zepto Life Technology Launches Plasma-Based FungiFlex® Mold Panel as CLIA Reference Laboratory Test
Zepto Life Technology
February 25, 2026
